Literature DB >> 25293318

In vivo techniques to investigate the internalization profile of opioid receptors.

Amynah A Pradhan1, Vivianne L Tawfik, Alycia F Tipton, Grégory Scherrer.   

Abstract

G-protein-coupled receptors (GPCRs) regulate a remarkable diversity of biological functions, and are thus often targeted for drug therapies. Receptor internalization is commonly observed following agonist binding and activation. Receptor trafficking events have been well characterized in cell systems, but the in vivo significance of GPCR internalization is still poorly understood. To address this issue, we have developed an innovative knock-in mouse model, where an opioid receptor is directly visible in vivo. These knockin mice express functional fluorescent delta opioid receptors (DOR-eGFP) in place of the endogenous receptor, and these receptors are expressed at physiological levels within their native environment. DOR-eGFP mice have proven to be an extraordinary tool in studying receptor neuroanatomy, real-time receptor trafficking in live neurons, and in vivo receptor internalization. We have used this animal model to determine the relationship between receptor trafficking in neurons and receptor function at a behavioral level. Here, we describe in detail the construction and characterization of this knockin mouse. We also outline how to use these mice to examine the behavioral consequences of agonist-specific trafficking at the delta opioid receptor. These techniques are potentially applicable to any GPCR, and highlight the powerful nature of this imaging tool.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25293318      PMCID: PMC4372127          DOI: 10.1007/978-1-4939-1708-2_7

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  74 in total

1.  Emergence of functional spinal delta opioid receptors after chronic ethanol exposure.

Authors:  Richard M van Rijn; Daniela I Brissett; Jennifer L Whistler
Journal:  Biol Psychiatry       Date:  2011-09-01       Impact factor: 13.382

Review 2.  Extending pharmacological spectrum of opioids beyond analgesia: multifunctional aspects in different pathophysiological states.

Authors:  Dharmraj Singh Sauriyal; Amteshwar Singh Jaggi; Nirmal Singh
Journal:  Neuropeptides       Date:  2011-01-03       Impact factor: 3.286

Review 3.  The delta opioid receptor: an evolving target for the treatment of brain disorders.

Authors:  Amynah A Pradhan; Katia Befort; Chihiro Nozaki; Claire Gavériaux-Ruff; Brigitte L Kieffer
Journal:  Trends Pharmacol Sci       Date:  2011-09-17       Impact factor: 14.819

4.  Ligand-directed trafficking of the δ-opioid receptor in vivo: two paths toward analgesic tolerance.

Authors:  Amynah A A Pradhan; Wendy Walwyn; Chihiro Nozaki; Dominique Filliol; Eric Erbs; Audrey Matifas; Christopher Evans; Brigitte L Kieffer
Journal:  J Neurosci       Date:  2010-12-08       Impact factor: 6.167

5.  Localization and regulation of fluorescently labeled delta opioid receptor, expressed in enteric neurons of mice.

Authors:  Daniel P Poole; Juan-Carlos Pelayo; Gregory Scherrer; Christopher J Evans; Brigitte L Kieffer; Nigel W Bunnett
Journal:  Gastroenterology       Date:  2011-05-27       Impact factor: 22.682

Review 6.  Molecular mechanisms of opioid receptor-dependent signaling and behavior.

Authors:  Ream Al-Hasani; Michael R Bruchas
Journal:  Anesthesiology       Date:  2011-12       Impact factor: 7.892

7.  Modality of hyperalgesia tested, not type of nerve damage, predicts pharmacological sensitivity in rat models of neuropathic pain.

Authors:  Amynah Amir Ali Pradhan; Xiao Hong Yu; Jennifer M A Laird
Journal:  Eur J Pain       Date:  2009-12-05       Impact factor: 3.931

8.  Differential modulation of mu- and delta-opioid receptor agonists by endogenous RGS4 protein in SH-SY5Y cells.

Authors:  Qin Wang; Lee-Yuan Liu-Chen; John R Traynor
Journal:  J Biol Chem       Date:  2009-05-05       Impact factor: 5.157

9.  Dissociation of the opioid receptor mechanisms that control mechanical and heat pain.

Authors:  Grégory Scherrer; Noritaka Imamachi; Yu-Qing Cao; Candice Contet; Françoise Mennicken; Dajan O'Donnell; Brigitte L Kieffer; Allan I Basbaum
Journal:  Cell       Date:  2009-06-12       Impact factor: 41.582

Review 10.  Molecular mechanism of β-arrestin-biased agonism at seven-transmembrane receptors.

Authors:  Eric Reiter; Seungkirl Ahn; Arun K Shukla; Robert J Lefkowitz
Journal:  Annu Rev Pharmacol Toxicol       Date:  2011-09-19       Impact factor: 13.820

View more
  6 in total

Review 1.  Molecular Pharmacology of δ-Opioid Receptors.

Authors:  Louis Gendron; Catherine M Cahill; Mark von Zastrow; Peter W Schiller; Graciela Pineyro
Journal:  Pharmacol Rev       Date:  2016-07       Impact factor: 25.468

Review 2.  The delta opioid receptor tool box.

Authors:  Ana Vicente-Sanchez; Laura Segura; Amynah A Pradhan
Journal:  Neuroscience       Date:  2016-06-24       Impact factor: 3.590

3.  Analysis of the distribution of spinal NOP receptors in a chronic pain model using NOP-eGFP knock-in mice.

Authors:  Akihiko Ozawa; Gloria Brunori; Andrea Cippitelli; Nicholas Toll; Jennifer Schoch; Brigitte L Kieffer; Lawrence Toll
Journal:  Br J Pharmacol       Date:  2018-05-06       Impact factor: 8.739

4.  Delta opioid receptor regulation of calcitonin gene-related peptide dynamics in the trigeminal complex.

Authors:  Laura S Moye; Kendra Siegersma; Isaac Dripps; Wiktor Witkowski; Elizaveta Mangutov; Dong Wang; Grégory Scherrer; Amynah A Pradhan
Journal:  Pain       Date:  2021-08-01       Impact factor: 7.926

5.  Strategy for Identification of Phosphorylation Levels of Low Abundance Proteins in Vivo for Which Antibodies Are not Available.

Authors:  Kozo Hayashi; Ryo Yamashita; Ritsuko Takami; Toshikatsu Matsui; Masamitsu Gotou; Tomoyuki Nishimoto; Hiroyuki Kobayashi
Journal:  J Cardiovasc Dev Dis       Date:  2017-10-08

6.  Forebrain delta opioid receptors regulate the response of delta agonist in models of migraine and opioid-induced hyperalgesia.

Authors:  Isaac J Dripps; Zachariah Bertels; Laura S Moye; Alycia F Tipton; Kendra Siegersma; Serapio M Baca; Brigitte L Kieffer; Amynah A Pradhan
Journal:  Sci Rep       Date:  2020-10-19       Impact factor: 4.996

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.